PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-14.1%
5Y CAGR+7.8%
Year-over-Year Change
Research and development spending
3Y CAGR
-14.1%/yr
vs -23.3%/yr prior
5Y CAGR
+7.8%/yr
Recent deceleration
Acceleration
+9.2pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $438416.00 | +7.6% |
| 2024 | $407431.00 | -13.0% |
| 2023 | $468536.00 | -32.2% |
| 2022 | $690937.00 | -24.6% |
| 2021 | $916249.00 | +204.2% |
| 2020 | $301221.00 | -34.5% |
| 2019 | $460052.00 | -77.0% |
| 2018 | $2.00M | +69.0% |
| 2017 | $1.18M | -16.0% |
| 2016 | $1.41M | - |